Corewell Health Southfield and Quest Diagnostics have completed a previously announced transaction to establish a laboratory ...

Quest Diagnostics has rolled out an ultrasensitive blood test to monitor multiple myeloma treatment, potentially sparing patients from more invasive and costly bone marrow aspirations. | Quest ...

Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

Quest expects the new blood test will support response monitoring in clinical trials.

A woman thinks her routine blood tests are behind her when she receives an explanation of benefits showing zero patient ...

If you have been wondering whether Quest Diagnostics at around US$185 per share is a fair deal or a stretch, you are not alone. The stock has returned 0.5% over the last 7 days, 6.5% over the past ...

Quest Diagnostics may be the preferred lab your health insurance, doctors, or specialists use for blood work or other samples. We’re reviewing its sub-brand Quest Health, from which you can order your ...

Quest Diagnostics reaffirmed as a buy: organic growth, macro demand, strong margins, investment-grade ratings, and dividend ...

In the last three months, 7 analysts have published ratings on Quest Diagnostics (NYSE:DGX), offering a diverse range of perspectives from bullish to bearish. In the table below, you'll find a summary ...

Quest Diagnostics stock snapshot after recent performance Quest Diagnostics (DGX) has been on investors’ radars after a mixed stretch, with the share price showing a 0.6% decline over the past day and ...

One of the top diagnostics specialists on the market published quarterly and full-year results. It not only scored a double beat on analyst projections, but its revenue guidance came out ahead as well ...

Jan Burnett thinks her routine blood tests are behind her when she receives an explanation of benefits showing zero patient ...